首页 | 本学科首页   官方微博 | 高级检索  
     检索      

Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA
作者姓名:张哲  汤灵玲  詹仁雅  童鹰  姚航平  杜理安
作者单位:First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China,First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China,First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China,First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China,Institute of Immunology,Zhejiang University,Hangzhou 310006,China,First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China
基金项目:Project supported by the Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry, China
摘    要:Objective: To investigate the anti-tumor efficacy of dendritic cell (DC)-based vaccines pulsed with tumor extracts or RNA in a mouse model of intracranial G422 glioblastoma. Methods: Bone marrow-derived DCs were pulsed ex vivo with tumor extracts or RNA. Ninety female mice harboring 4-day-old intracranial G422 glioblastomas and 126 normal mice were treated with three spaced one week apart subcutaneous injections either with PBS, unpulsed DCs, G422 tumor extracts, RNA, DCs pulsed with G422 tumor extracts (DC/extract) or with RNA (DC/RNA). Seven days after the third immunization of normal mice, the spleens of 36 of them were harvested for cytotoxic T lyphocyte (CTL) assays and the others were challenged in the brain with G422 tumor cells. All the treated mice were followed for survival. Some mice brains were removed and examined pathologically when they died. Results: Immunization using DC/extract or DC/RNA significantly induced G422-specific CTL responses compared with control groups (P<0.01). Vaccinatio


Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA
ZHANG Zhe,TANG Ling-ling,ZHAN Ren-ya TONG Ying,YAO Hang-ping,DU Li-an.Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA[J].Journal of Zhejiang University Science,2004(10).
Authors:ZHANG Zhe  TANG Ling-ling  ZHAN Ren-ya TONG Ying  YAO Hang-ping  DU Li-an
Abstract:Objective: To investigate the anti-tumor efficacy of dendritic cell (DC)-based vaccines pulsed with tumor extracts or RNA in a mouse model of intracranial G422 glioblastoma. Methods: Bone marrow-derived DCs were pulsed ex vivo with tumor extracts or RNA. Ninety female mice harboring 4-day-old intracranial G422 glioblastomas and 126 normal mice were treated with three spaced one week apart subcutaneous injections either with PBS, unpulsed DCs, G422 tumor extracts, RNA, DCs pulsed with G422 tumor extracts (DC/extract) or with RNA (DC/RNA). Seven days after the third immunization of normal mice, the spleens of 36 of them were harvested for cytotoxic T lyphocyte (CTL) assays and the others were challenged in the brain with G422 tumor cells. All the treated mice were followed for survival. Some mice brains were removed and examined pathologically when they died. Results: Immunization using DC/extract or DC/RNA significantly induced G422-specific CTL responses compared with control groups (P<0.01). Vaccination with DC/extract or DC/RNA, either prior to G422 tumor challenge or in tumor-harboring mice, significantly prolonged survival compared with other control groups (P<0.01). Conclusion: DCs pulsed with tumor extracts or RNA derived from autologous tumors has potential antitumor effects via activation of cell-mediated immunity. Our results suggest a useful therapeutic strategy against gliomas.
Keywords:Dendritic cell  Glioma  Immunotherapy
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号